Paclitaxel liposome (Lipusu) based chemotherapy combined with immunotherapy for advanced non-small cell lung cancer: a multicenter, retrospective real-world study

被引：0
|
作者：
Ran Li
Hongge Liang
Jun Li
Zhenyu Shao
Donghong Yang
Jing Bao
Keqiang Wang
Wen Xi
Zhancheng Gao
Renhua Guo
Xinlin Mu
机构：
[1] Peking University People’s Hospital,Department of Respiratory and Critical Care Medicine, Lung Cancer Center
[2] The First Affiliated Hospital of Nanjing Medical University,Department of Oncology
[3] Qilu Hospital of Shandong University,Department of Radiation Oncology
来源：
BMC Cancer | / 24卷
关键词：
Paclitaxel liposome; Immunotherapy; Immune checkpoint inhibitor; Non-small cell lung cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Paclitaxel liposome (Lipusu) based chemotherapy combined with immunotherapy for advanced non-small cell lung cancer: a multicenter, retrospective real-world study
    Li, Ran
    Liang, Hongge
    Li, Jun
    Shao, Zhenyu
    Yang, Donghong
    Bao, Jing
    Wang, Keqiang
    Xi, Wen
    Gao, Zhancheng
    Guo, Renhua
    Mu, Xinlin
    BMC CANCER, 2024, 24 (01)
  • [2] Checkpoint based immunotherapy in non-small cell lung cancer: a real-world retrospective study
    Liguori, Luigi
    Giorgio, Gabriele
    Polcaro, Giovanna
    Pagliara, Valentina
    Malandrino, Domenico
    Perri, Francesco
    Cascella, Marco
    Ottaiano, Alessandro
    Conti, Valeria
    Servetto, Alberto
    Bianco, Roberto
    Pepe, Stefano
    Sabbatino, Francesco
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [3] Paclitaxel Liposome Combined with Immunotherapy in the First-Line Treatment of Advanced NSCLC: A Multicenter Real-World Study
    Jiang, L.
    Zheng, D.
    Ni, J.
    Ding, H.
    Zhao, Y.
    Heng, W.
    Shang, Y.
    Cai, X.
    Yan, J.
    Wang, J.
    Guo, J.
    Tan, X.
    Hong, X.
    Zhang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S248 - S249
  • [4] Neoadjuvant Camrelizumab for Non-Small Cell Lung Cancer: A Retrospective Multicenter, Real-World Study (CTONG2004)
    Liu, Si-Yang
    Chen, Qixun
    Zhou, Chengzhi
    Zhang, Huizhong
    Li, Wen
    Chen, Jianhua
    Hu, Jian
    Wu, Lin
    Chen, Qunqing
    Dai, Qiangsheng
    Shan, Jian-Zhen
    Xu, Fei
    Liu, Si-Yang Maggie
    Wu, Yi-Long
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (07) : 2257 - 2265
  • [5] Efficacy and safety of combined immunotherapy and antiangiogenic therapy for advanced non-small cell lung cancer: a real-world observation study
    Ke Ma
    Qianqian Guo
    Xingya Li
    BMC Pulmonary Medicine, 23
  • [6] Efficacy and safety of combined immunotherapy and antiangiogenic therapy for advanced non-small cell lung cancer: a real-world observation study
    Ma, Ke
    Guo, Qianqian
    Li, Xingya
    BMC PULMONARY MEDICINE, 2023, 23 (01)
  • [7] Real-world clinical outcomes of neoadjuvant immunotherapy combined with chemotherapy in resectable non-small cell lung cancer
    Wu, Junqi
    Hou, Likun
    Zhao, Yue
    Yu, Xin
    Xu, Long
    Ning, Ye
    Deng, Jiajun
    Sun, Ke
    Zhang, Jie
    Wu, Chunyan
    Zhu, Yuming
    Zhao, Deping
    She, Yunlang
    Su, Chunxia
    Chen, Chang
    Haoran, E.
    LUNG CANCER, 2022, 165 : 115 - 123
  • [8] Treatment options for tumor progression after initial immunotherapy in advanced non-small cell lung cancer: A real-world study
    Li, Ying
    Zhao, Junfeng
    Li, Ruyue
    Yao, Xiujing
    Dong, Xue
    Zhang, Ruidan
    Li, Yintao
    NEOPLASIA, 2024, 57
  • [9] Real-world outcomes of immunotherapy with or without chemotherapy in first-line treatment of advanced non-small cell lung cancer
    Pelicon, Veronika
    Cufer, Tanja
    Knez, Lea
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [10] Real-World Efficacy and Safety of Anlotinib With and Without Immunotherapy in Advanced Non-Small Cell Lung Cancer
    Xiong, Qi
    Qin, Boyu
    Xin, Lingli
    Yang, Bo
    Song, Qi
    Wang, Yu
    Zhang, Sujie
    Hu, Yi
    FRONTIERS IN ONCOLOGY, 2021, 11
12345